{"id":"https://openalex.org/W7202008265","doi":null,"title":"Fibril\u00b7laci\u00f3 Auricular Secund\u00e0ria a Ibrutinib: A prop\u00f2sit d\u2019un cas","display_name":"Fibril\u00b7laci\u00f3 Auricular Secund\u00e0ria a Ibrutinib: A prop\u00f2sit d\u2019un cas","publication_year":2022,"publication_date":"2022-01-01","ids":{"openalex":"https://openalex.org/W7202008265"},"language":"ca","primary_location":{"id":"pmh:oai:raco.cat:article/1500000000002227","doi":null,"is_oa":true,"landing_page_url":"http://raco.cat/index.php/circular/article/view/1500000000002227","pdf_url":"https://raco.cat/index.php/circular/article/download/1500000000002227/555430","source":{"id":"https://openalex.org/S4306401311","display_name":"RACO (Revistes Catalanes amb Acc\u00e9s Obert) (Consorci de Serveis Universitaris de Catalunya)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210090028","host_organization_name":"Consorci de Serveis Universitaris de Catalunya","host_organization_lineage":["https://openalex.org/I4210090028"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"RACO (Revistes Catalanes amb Acc\u00e9s Obert)","raw_type":"info:eu-repo/semantics/article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://raco.cat/index.php/circular/article/download/1500000000002227/555430","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5091717101","display_name":"Gemma Garreta Fontelles","orcid":"https://orcid.org/0000-0002-4635-5785","observed_orcids":["https://orcid.org/0000-0002-4635-5785"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Garreta Fontelles, Gemma","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033184189","display_name":"Nuria Meca Casasnovas","orcid":"https://orcid.org/0000-0001-5634-3588","observed_orcids":["https://orcid.org/0000-0001-5634-3588"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Meca Casasnovas, N\u00faria","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078894281","display_name":"Cristina Sangrador Pelluz","orcid":"https://orcid.org/0000-0002-8844-2684","observed_orcids":["https://orcid.org/0000-0002-8844-2684"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sangrador Pelluz, Cristina","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5065058530","display_name":"Jordi Nicol\u00e1s Pic\u00f3","orcid":"https://orcid.org/0000-0002-0944-1764","observed_orcids":["https://orcid.org/0000-0002-0944-1764"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicol\u00e1s Pic\u00f3, Jordi","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":true,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.614300012588501,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.614300012588501,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10065","display_name":"Atrial Fibrillation Management and Outcomes","score":0.1565999984741211,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11535","display_name":"Chemotherapy-induced cardiotoxicity and mitigation","score":0.0869000032544136,"subfield":{"id":"https://openalex.org/subfields/2705","display_name":"Cardiology and Cardiovascular Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ibrutinib","display_name":"ibrutinib","score":0.9980000257492065},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.906000018119812},{"id":"https://openalex.org/keywords/cardiac-arrhythmia","display_name":"cardiac arrhythmias","score":0.5379999876022339},{"id":"https://openalex.org/keywords/chronic-lymphocytic-leukemia","display_name":"chronic lymphocytic leukemia","score":0.7699999809265137},{"id":"https://openalex.org/keywords/waldenstrom-macroglobulinemia","display_name":"Waldenstr\u00f6m macroglobulinemia","score":0.9710000157356262},{"id":"https://openalex.org/keywords/mantle-cell-lymphoma","display_name":"mantle cell lymphoma","score":0.9940000176429749},{"id":"https://openalex.org/keywords/hypertension","display_name":"hypertension","score":0.3149999976158142},{"id":"https://openalex.org/keywords/bleeding-risk","display_name":"bleeding risk","score":0.6439999938011169},{"id":"https://openalex.org/keywords/oncohematologic-patients","display_name":"oncohematologic patients","score":0.6729999780654907},{"id":"https://openalex.org/keywords/adverse-drug-reactions","display_name":"adverse drug reactions","score":0.45399999618530273},{"id":"https://openalex.org/keywords/pharmacovigilance","display_name":"pharmacovigilance","score":0.7630000114440918}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5636000037193298},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.25060001015663147},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.1915999948978424},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.16169999539852142},{"id":"https://openalex.org/C98045186","wikidata":"https://www.wikidata.org/wiki/Q205663","display_name":"Process (computing)","level":2,"score":0.16009999811649323},{"id":"https://openalex.org/C126838900","wikidata":"https://www.wikidata.org/wiki/Q77604","display_name":"Radiology","level":1,"score":0.1597999930381775},{"id":"https://openalex.org/C2776401178","wikidata":"https://www.wikidata.org/wiki/Q12050496","display_name":"Feature (linguistics)","level":2,"score":0.15729999542236328},{"id":"https://openalex.org/C81917197","wikidata":"https://www.wikidata.org/wiki/Q628760","display_name":"Selection (genetic algorithm)","level":2,"score":0.15680000185966492},{"id":"https://openalex.org/C180016635","wikidata":"https://www.wikidata.org/wiki/Q2712821","display_name":"Compression (physics)","level":2,"score":0.15489999949932098},{"id":"https://openalex.org/C2988078883","wikidata":"https://www.wikidata.org/wiki/Q109374671","display_name":"Doppler ultrasound","level":2,"score":0.15299999713897705}],"mesh":[],"locations_count":1,"locations":[{"id":"pmh:oai:raco.cat:article/1500000000002227","doi":null,"is_oa":true,"landing_page_url":"http://raco.cat/index.php/circular/article/view/1500000000002227","pdf_url":"https://raco.cat/index.php/circular/article/download/1500000000002227/555430","source":{"id":"https://openalex.org/S4306401311","display_name":"RACO (Revistes Catalanes amb Acc\u00e9s Obert) (Consorci de Serveis Universitaris de Catalunya)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210090028","host_organization_name":"Consorci de Serveis Universitaris de Catalunya","host_organization_lineage":["https://openalex.org/I4210090028"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"RACO (Revistes Catalanes amb Acc\u00e9s Obert)","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"pmh:oai:raco.cat:article/1500000000002227","doi":null,"is_oa":true,"landing_page_url":"http://raco.cat/index.php/circular/article/view/1500000000002227","pdf_url":"https://raco.cat/index.php/circular/article/download/1500000000002227/555430","source":{"id":"https://openalex.org/S4306401311","display_name":"RACO (Revistes Catalanes amb Acc\u00e9s Obert) (Consorci de Serveis Universitaris de Catalunya)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210090028","host_organization_name":"Consorci de Serveis Universitaris de Catalunya","host_organization_lineage":["https://openalex.org/I4210090028"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"RACO (Revistes Catalanes amb Acc\u00e9s Obert)","raw_type":"info:eu-repo/semantics/article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W7202008265.pdf","grobid_xml":"https://content.openalex.org/works/W7202008265.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2943924269","https://openalex.org/W6982320791","https://openalex.org/W2943942353","https://openalex.org/W2889134442","https://openalex.org/W4297179783","https://openalex.org/W2527605644","https://openalex.org/W4296124154","https://openalex.org/W4412805669","https://openalex.org/W4388561327","https://openalex.org/W2655216661"],"abstract_inverted_index":{"8":[0],"/":[1,8],"Circular":[2],"Farmac\u00e8utica":[3],"2022":[4],"vol.80-1":[5],"Primer":[6],"Quadrimestre":[7],"Col\u2022legi":[9],"de":[10,12,23,86,97,109,128,132,142,150,158,166,192,243,251,267,276,286,290,294,299,311,341],"Farmac\u00e8utics":[11],"Barcelona":[13],"INTRODUCCI\u00d3La":[14],"millora":[15],"en":[16,33,43,48,68,79,91,95,119,139,215,337,345],"el":[17,182,229,333],"pron\u00f2stic":[18],"del":[19,168,255,322],"c\u00e0ncer":[20,82,104],"i":[21,72,148,153,180,188,205,218,228,259,318,332],"l'\u00fas":[22],"ter\u00e0pies":[24],"dirigides":[25],"van":[26],"augmentar":[27],"dr\u00e0sticament":[28],"la":[29,38,44,69,73,117,129,143,202,206,222,226,257,260,272,277],"prevalen\u00e7a":[30,85],"d'arr\u00edtmies":[31],"card\u00edaques":[32],"pacients":[34,55,80,102,163],"oncohematol\u00f2gics.No":[35],"obstant":[36],"aix\u00f2,":[37],"seva":[39,74],"incid\u00e8ncia":[40,75],"est\u00e0":[41],"subestimada":[42],"literatura,":[45],"ja":[46],"que":[47,171,197,263],"els":[49,216,283,308],"assajos":[50,217],"cl\u00ednics":[51],"s'han":[52],"excl\u00f2s":[53],"als":[54,162,315],"amb":[56,81,103,107,164,236,347],"cardiopaties":[57],"1":[58],".La":[59,84],"fibril\u2022laci\u00f3":[60],"auricular":[61],"(FA)":[62],"\u00e9s":[63,76,88,124,280],"l'arr\u00edtmia":[64],"mantinguda":[65],"m\u00e9s":[66,213],"freq\u00fcent":[67],"poblaci\u00f3":[70],"general":[71],"substancialment":[77],"major":[78],"2":[83],"FA":[87,118,227],"molt":[89],"variable":[90],"les":[92,190,252],"diferents":[93],"publicacions":[94],"funci\u00f3":[96],"si":[98],"inclouen":[99],"nom\u00e9s":[100],"a":[101,116,156,201],"actiu":[105],"o":[106,112,292],"antecedents":[108],"malaltia":[110],"oncohematol\u00f2gica":[111],"b\u00e9,":[113],"fan":[114],"refer\u00e8ncia":[115],"cirurgia":[120],"oncol\u00f2gica":[121],"3":[122],".Ibrutinib":[123],"un":[125],"inhibidor":[126],"oral":[127],"tirosina":[130],"cinasa":[131],"Bruton":[133],"(BTK),":[134],"aprovat":[135],"per":[136,161,200,240,271],"al":[137,173,234,302,320],"tractament":[138,346],"primera":[140],"l\u00ednia":[141,160],"leuc\u00e8mia":[144,342],"limfoc\u00edtica":[145,343],"cr\u00f2nica":[146,344],"(LLC)":[147],"macroglobulinema":[149],"Waldenstrom":[151],"(WM),":[152],"indicat":[154],"com":[155],"agent":[157],"segona":[159],"limfoma":[165],"c\u00e8l\u2022lules":[167],"mantell":[169],"(MCL).Pel":[170],"fa":[172],"seu":[174],"mecanisme":[175],"d'acci\u00f3,":[176],"ibrutinib":[177,237],"inhibeix":[178],"selectivament":[179],"irreversiblement":[181],"BTK":[183,258],"dins":[184],"dels":[185,335],"limf\u00f2cits":[186],"B":[187],"bloqueja":[189],"vies":[191],"senyalitzaci\u00f3":[193],"intracel\u2022lulars":[194],"activades":[195],"constitutivament,":[196],"s\u00f3n":[198,221],"cr\u00edtiques":[199],"migraci\u00f3":[203],"cel\u2022lular":[204],"superviv\u00e8ncia":[207],"4":[208],".Els":[209],"efectes":[210,336],"adversos":[211],"cardiovasculars":[212],"descrits":[214],"l'experi\u00e8ncia":[219],"cl\u00ednica":[220],"hipertensi\u00f3":[223],"arterial":[224],"(HTA),":[225],"sagnat.El":[230],"risc":[231,298],"d'hemorr\u00e0gia":[232],"associat":[233,301],"tracta-ment":[235],"es":[238,247,304,328],"dona":[239,305],"una":[241,249,265,338],"inhibici\u00f3":[242,250,266],"l'agregaci\u00f3":[244,268],"plaquet\u00e0ria.En":[245],"concret,":[246],"produeix":[248],"dianes":[253],"terap\u00e8utiques":[254],"f\u00e0rmac,":[256],"TEC":[261],"cinasa,":[262],"comporta":[264],"plaquet\u00e0ria":[269],"intervinguda":[270],"glucoprote\u00efna":[273],"VI.Aquesta":[274],"alteraci\u00f3":[275],"coagulaci\u00f3":[278,287],"no":[279],"detectable":[281],"mitjan\u00e7ant":[282],"par\u00e0metres":[284],"cl\u00e0ssics":[285],"(p.e.":[288],"temps":[289,293,323],"protrombina":[291],"tromboplastina":[295],"parcial":[296],"activada).El":[297],"sagnat":[300],"f\u00e0rmac":[303],"principalment":[306],"durant":[307],"primers":[309],"mesos":[310,317],"tractament,":[312],"sent":[313],"m\u00e0xim":[314],"sis":[316],"disminueix":[319],"llarg":[321],"4,5":[324],".En":[325],"aquest":[326],"cas":[327],"presenta":[329],"l'abordatge":[330],"terap\u00e8utic":[331],"maneig":[334],"pacient":[339],"diagnosticada":[340],"ibrutinib.":[348]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-08-09T00:00:00"}